文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血:血管内治疗与显微外科夹闭的患者报告结局比较

Patient-Reported Outcome for Endovascular Treatment versus Microsurgical Clipping in Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2021-09-06

该横断面电话调查研究纳入卡塔尔多哈哈马德综合医院2017至2019年接受动脉瘤治疗的成人患者,比较血管内治疗(N=32)与显微外科夹闭(N=32)的患者报告结局。主要指标为简版卒中特异性生活质量量表(SS-QoL),两组平均分分别为4.23(±0.77)与4.19(±0.19),差异无统计学意义(P=0.90);次要指标改良Rankin量表(mRS)在血管内治疗组更高(P=0.04)。作者认为本研究未发现两种治疗在患者报告结局上的差异,建议未来治疗研究纳入患者报告结局。

要点

  • 两组SS-QoL平均分相近(4.23对4.19,P=0.90),患者报告结局未见差异。
  • 血管痉挛是不论何种干预均与SS-QoL相关的临床变量。
  • 次要结局中血管内治疗组mRS评分更高(P=0.04)。

核心结论

  • 本研究未发现血管内治疗与显微外科夹闭在患者报告结局(SS-QoL)上的差异。
  • 作者建议未来治疗研究应纳入患者报告结局,以从患者视角识别潜在差异。

研究设计与样本

  • 在卡塔尔多哈哈马德综合医院开展的横断面电话调查,时间为2017至2019年。
  • 研究对象为成人动脉瘤患者,血管内治疗N=32,显微外科夹闭N=32,从手术记录和医院电子健康记录中识别。
  • 主要结局为简版卒中特异性生活质量量表(SS-QoL),次要结局为筛查患者(n=137)的临床医生报告改良Rankin量表(mRS)。

主要发现

  • SS-QoL平均分:血管内治疗4.23(标准差±0.77),外科夹闭4.19(±0.19),P=0.90。
  • 探索性分析中,身体领域平均分血管内治疗3.17±0.60、外科夹闭2.98±0.66。
  • 探索性分析中,心理社会领域平均分血管内治疗4.43±0.85、外科夹闭4.18±0.92。
  • 多变量分析中,除血管痉挛外,无论接受何种干预,无临床变量与SS-QoL显著相关。
  • 次要结局分析中,血管内治疗组mRS评分更高(P=0.04)。

关键数值与推荐

  • 主要结局采用简版卒中特异性生活质量量表(SS-QoL)。
  • 次要结局采用筛查的临床医生报告改良Rankin量表(mRS),覆盖所有筛查患者(n=137)。
  • SS-QoL组间比较P=0.90,mRS组间比较P=0.04。

临床怎么用

  • 对于动脉瘤性蛛网膜下腔出血,血管内治疗与显微外科夹闭在患者报告的生活质量上未见明显差异。
  • 临床决策可结合mRS等临床结局与患者报告结局综合评估,而非仅依赖单一维度。

局限性

  • 横断面电话调查设计,样本量较小(每组N=32)。
  • 患者报告结局为调查时点采集,可能受回忆与应答方式影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aneurysmal subarachnoid hemorrhage has a high mortality with significant impact on quality of life despite effective management strategies including endovascular treatment and/or microsurgical clipping. Although the modalities have undergone clinical comparison, they have not been evaluated on patient-reported outcomes (PROs). This study compared endovascular versus microsurgical treatment using a PRO measure. METHODS: We conducted a cross-sectional telephonic survey of adult patients conducted at Hamad General Hospital, Doha, Qatar between 2017 and 2019. Candidate study participants were identified from procedure logs and hospital electronic health records for endovascular treatment (N = 32) versus microsurgical clipping (N = 32) of cerebral aneurysm. The primary outcome measure was the short version of the Stroke-Specific Quality of Life (SS-QoL) measure. The secondary outcome measure was the screened clinician-reported modified Rankin Scale (mRS) for all screened patients (n = 137). Mean scores were compared for the 2 treatment groups. RESULTS: The SS-QoL mean score was 4.23 (standard deviation ± 0.77) in endovascular treatment and 4.19 ± 0.19 in surgical clipping (P = 0.90). In exploratory analysis, mean physical domain score was 3.17 ± 0.60 versus 2.98 ± 0.66 in endovascular treatment and surgical clipping groups, respectively. Mean psychosocial domain scores were 4.43 ± 0.85 versus 4.18 ± 0.0.92, respectively. In multivariable analysis, none of the clinical variables were significantly related to SS-QoL except vasospasm irrespective of intervention received. In secondary outcome analysis, modified Rankin Scale score was higher for endovascular treatment (P = 0.04). CONCLUSIONS: Published evidence has supported clinical benefits of endovascular treatment for cerebral aneurysm treatment, but this study did not find any difference in PROs. Future studies of treatments should include PRO to identify potential differences from the patient's perspective.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ali A, Alrabayah T, Abdelhafez I, et al. Patient-Reported Outcome for Endovascular Treatment versus Microsurgical Clipping in Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2021. PMID: 34500096. doi:10.1016/j.wneu.2021.08.131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。